From the Journals

Pegboard test useful in upper-extremity motor assessments in Parkinson’s


 

FROM MOVEMENT DISORDERS

Pegboard tests are an effective way to assess the progression of upper-extremity motor deficits in patients with early-stage Parkinson’s disease (PD), according to a research letter from Sebastian Heitzel, PhD, and his associates.

As part of the prospective MODEP study, motor performance of early-stage PD patients, midstage PD patients, and a healthy control group were assessed biannually over a 4-year period using the pegboard test. E-PD and M-PD patients performed significantly worse on all pegboard tasks than did people in the control group.

©designer491/Thinkstock
The “turning pegs” and “inserting pegs” tasks were of particular significance to the E-PD and control group. The rate at which E-PD patients completed both tasks increased at rates of 6% per year and 3% per year, respectively, compared with a decrease of 3% per year and 1% per year, respectively, in the control group.

Movement Disorder Society Unified Parkinson’s Disease Rating Scale part III scores worsened in E-PD patients, compared with controls, but slightly improved in M-PD patients.

“Pegboard is cost- and time-effective, does not require medically trained staff, and provides objective and reliable markers of upper-extremity motor deficits,” the investigators noted.

Find the full research letter in Movement Disorders (2017. doi: 10.1002/mds.27062).

Recommended Reading

Why Do Patients Discontinue Botulinum Toxin for Dystonia?
MDedge Neurology
How to Diagnose and Treat Rare Movement Disorders
MDedge Neurology
Vets with TBIs are more likely to develop Parkinson’s
MDedge Neurology
Apomorphine pump dramatically decreases ‘off’ time in Parkinson’s
MDedge Neurology
Can Cannabis Help Patients With Parkinson’s Disease?
MDedge Neurology
Neurologists Review the Data on Treatments for Spinocerebellar Ataxias
MDedge Neurology
Inhaled Levodopa Treats Off Periods in Phase III Trial
MDedge Neurology
New Tool Can Distinguish Between Tremor Syndromes
MDedge Neurology
Promising phase II results for Rytary reformulation for Parkinson’s
MDedge Neurology
App allows monitoring of drug effects in Parkinson’s
MDedge Neurology